NATCO Pharma Launches Generic Blood Cancer Treatment Capsules in US

NATCO Pharma has launched generic Pomalidomide capsules in the US, treating adult patients with blood and bone marrow cancers, including multiple myeloma and Kaposi sarcoma. The generic version of Celgene's Pomalyst is available in multiple strengths and distributed through specialty pharmacies. The launch, in partnership with Breckenridge Pharmaceutical, aims to improve access and affordability, with copay assistance offered to eligible patients. NATCO plans to introduce more specialty medicines in the future.